This company seems to have been delisted
Reason: Filed for bankruptcy
Source: https://www.fiercebiotech.com/biotech/vbi-vaccines-secures-court-protection-it-restructures-seeks-buyers
Reason: Filed for bankruptcy
Source: https://www.fiercebiotech.com/biotech/vbi-vaccines-secures-court-protection-it-restructures-seeks-buyers
VBI Vaccines
VBIV
0,05633 €
Share price
0.00%
Change (1 day)
-90.01%
Change (1 year)
Categories
P/S ratio for VBI Vaccines (VBIV)
P/S ratio on July 29, 2025 (TTM) : 0.1990
According to VBI Vaccines 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.3426. At the end of 2024 the company had a P/S ratio of 1.52.
P/S ratio history for VBI Vaccines from 2008 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.52 | -5.38% |
| 2023 | 1.60 | -98.28% |
| 2022 | 93.3 | -90.22% |
| 2021 | 954 | 52.09% |
| 2020 | 627 | 466.43% |
| 2019 | 111 | 138.58% |
| 2018 | 46.4 | -85.26% |
| 2017 | 315 | 53.04% |
| 2016 | 206 | -79.54% |
| 2015 | > 1000 | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A | |
| 2008 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | 92.5 | 46,377.50% | 🇺🇸 USA |
 Myriad Genetics MYGN | 0.4857 | 144.03% | 🇺🇸 USA |
 Curis CRIS | 1.95 | 879.70% | 🇺🇸 USA |